Table Filtering
Submissions
GlyTouCan
Glycan Structure Repository
GlyComb
Glycoconjugate Repository
GlycoPOST
Glycomics MS raw data Repository
UniCarb-DR
Glycomics MS Repository for glycan annotations from GlycoWorkbench
All Resources
Genes / Proteins / Lipids Glycans / Glycoconjugates Glycomes Pathways / Interactions / Diseases / Organisms
GlycoNAVI Proteins
GlycoNAVI-Proteins is dataset of glycan and protein information. This is the content of GlycoNAVI.
| Source | Last Updated |
|---|---|
| GlycoNAVI Proteins | September 04, 2024 |
| PDB ID ▼ | UniProt ID | Title | Descriptor |
|---|---|---|---|
| 7MZI | 7MZI | SARS-CoV-2 receptor binding domain bound to Fab WCSL 129 | |
| 7MZH | P0DTC2 | SARS-CoV-2 receptor binding domain bound to Fab WCSL 119 | |
| 7MZH | 7MZH | SARS-CoV-2 receptor binding domain bound to Fab WCSL 119 | |
| 7MZG | P0DTC2 | SARS-CoV-2 receptor binding domain bound to Fab PDI 42 | |
| 7MZG | 7MZG | SARS-CoV-2 receptor binding domain bound to Fab PDI 42 | |
| 7MZF | P0DTC2 | SARS-CoV-2 receptor binding domain bound to Fab PDI 37 | |
| 7MZF | 7MZF | SARS-CoV-2 receptor binding domain bound to Fab PDI 37 | |
| 7MYZ | Q08722 | Structure of the full length 5-TM receptor CD47 bound to Fab B6H12 | |
| 7MYZ | P0ABE7 | Structure of the full length 5-TM receptor CD47 bound to Fab B6H12 | |
| 7MYZ | 7MYZ | Structure of the full length 5-TM receptor CD47 bound to Fab B6H12 | |
| 7MY3 | P0DTC2 | CryoEM structure of neutralizing nanobody Nb12 in complex with SARS-CoV2 spike | |
| 7MY3 | 7MY3 | CryoEM structure of neutralizing nanobody Nb12 in complex with SARS-CoV2 spike | |
| 7MY2 | 7MY2 | CryoEM structure of neutralizing nanobody Nb30 in complex with SARS-CoV2 spike | |
| 7MY2 | P0DTC2 | CryoEM structure of neutralizing nanobody Nb30 in complex with SARS-CoV2 spike | |
| 7MXP | P0DTC2 | Cryo-EM structure of NTD-directed neutralizing antibody LP5 Fab in complex with SARS-CoV-2 S2P spike | |
| 7MXP | 7MXP | Cryo-EM structure of NTD-directed neutralizing antibody LP5 Fab in complex with SARS-CoV-2 S2P spike | |
| 7MXI | P01854 | IgE-Fc in complex with DARPins E2_79 and E3_53 | |
| 7MXI | 7MXI | IgE-Fc in complex with DARPins E2_79 and E3_53 | |
| 7MXI | L7MTK7 | IgE-Fc in complex with DARPins E2_79 and E3_53 | |
| 7MXH | P29016 | CD1c with antigen analogue 3 | |
| 7MXH | P29017 | CD1c with antigen analogue 3 | |
| 7MXH | P61769 | CD1c with antigen analogue 3 | |
| 7MXF | P29016 | CD1c with antigen analogue 2 | |
| 7MXF | P29017 | CD1c with antigen analogue 2 | |
| 7MXF | P61769 | CD1c with antigen analogue 2 | |
| 7MXE | 7MXE | Ab1245 Fab in complex with BG505 SOSIP.664 and 8ANC195 Fab | |
| 7MXE | Q2N0S6 | Ab1245 Fab in complex with BG505 SOSIP.664 and 8ANC195 Fab | |
| 7MXD | I6NF57 | Cryo-EM structure of broadly neutralizing V2-apex-targeting antibody J038 in complex with HIV-1 Env | |
| 7MXD | 7MXD | Cryo-EM structure of broadly neutralizing V2-apex-targeting antibody J038 in complex with HIV-1 Env | |
| 7MX4 | P29016 | CD1c with antigen analogue 1 | |
| 7MX4 | P29017 | CD1c with antigen analogue 1 | |
| 7MX4 | P61769 | CD1c with antigen analogue 1 | |
| 7MWX | 7MWX | Structure of the core ectodomain of the hepatitis C virus envelope glycoprotein 2 with tamarin CD81 | |
| 7MWX | A0A2I6PIY1 | Structure of the core ectodomain of the hepatitis C virus envelope glycoprotein 2 with tamarin CD81 | |
| 7MWX | Q9N0J9 | Structure of the core ectodomain of the hepatitis C virus envelope glycoprotein 2 with tamarin CD81 | |
| 7MWW | A0A2I6PIY1 | Structure of hepatitis C virus envelope full-length glycoprotein 2 (eE2) from J6 genotype | |
| 7MWW | 7MWW | Structure of hepatitis C virus envelope full-length glycoprotein 2 (eE2) from J6 genotype | |
| 7MW6 | P0DTC2 | Structure of the SARS-CoV-2 Spike trimer with three RBDs up in complex with the Fab fragment of human neutralizing antibody clone 2 | |
| 7MW6 | 7MW6 | Structure of the SARS-CoV-2 Spike trimer with three RBDs up in complex with the Fab fragment of human neutralizing antibody clone 2 | |
| 7MW5 | P0DTC2 | Structure of the SARS-CoV-2 Spike trimer with one RBD down in complex with the Fab fragment of human neutralizing antibody clone 2 | |
| 7MW5 | 7MW5 | Structure of the SARS-CoV-2 Spike trimer with one RBD down in complex with the Fab fragment of human neutralizing antibody clone 2 | |
| 7MW4 | P0DTC2 | Structure of the SARS-CoV-2 Spike trimer with one RBD down in complex with the Fab fragment of human neutralizing antibody clone 6 | |
| 7MW4 | 7MW4 | Structure of the SARS-CoV-2 Spike trimer with one RBD down in complex with the Fab fragment of human neutralizing antibody clone 6 | |
| 7MW3 | P0DTC2 | Structure of the SARS-CoV-2 Spike trimer with two RBDs down in complex with the Fab fragment of human neutralizing antibody clone 6 | |
| 7MW3 | 7MW3 | Structure of the SARS-CoV-2 Spike trimer with two RBDs down in complex with the Fab fragment of human neutralizing antibody clone 6 | |
| 7MW2 | P0DTC2 | Structure of the SARS-CoV-2 Spike trimer with all RBDs down in complex with the Fab fragment of human neutralizing antibody clone 6 | |
| 7MW2 | 7MW2 | Structure of the SARS-CoV-2 Spike trimer with all RBDs down in complex with the Fab fragment of human neutralizing antibody clone 6 | |
| 7MUA | Q6JC40 | Structure of the adeno-associated virus 9 capsid at pH pH 5.5 in complex with terminal galactose | |
| 7MU8 | P13688 | Structure of the minimally glycosylated human CEACAM1 N-terminal domain | |
| 7MTZ | Q6JC40 | Structure of the adeno-associated virus 9 capsid at pH pH 7.4 in complex with terminal galactose |
